Clinical study of single-port subxiphoid thoracoscopy under spontaneous breathing anesthesia for thymoma treatment
Objective To analyze the clinical value of single-port subxiphoid thoracoscopy under spontane-ous breathing anesthesia for thymoma treatment.Methods The study included 42 patients diagnosed with thymoma in the Department of Cardiothoracic Surgery from March 2021 to March 2023.Patients were divided into two groups according to surgical method:Group A(n=21)underwent single-port subxiphoid thoracosco-py under spontaneous breathing anesthesia,and Group B(n=21)underwent lateral thoracoscopy under gen-eral anesthesia with double-lumen tracheal intubation.Perioperative indicators and follow-up results were com-pared between the two groups.Results Group A showed superior outcomes compared to Group B in terms of operation time,intraoperative blood loss,postoperative drainage retain time,postoperative drainage volume,hospital stay after operation and early postoperative stage pain visual analogue score(P＜0.05).There were no significant differences in complications and total hospitalization costs between the two groups(P＞0.05).Follow-up showed no tumor recurrence or metastasis in either group.Conclusion Single-port subxiphoid thoracoscopy under spontaneous breathing anesthesia demonstrates several advantages over lateral thoracoscopy under general anesthesia for thymoma treatment.These include enhanced safety,less trauma,less intraopera-tive bleeding,milder postoperative pain,faster recovery,and comparable hospitalization costs,which is worthy of further clinical promotion.
NETL
NSTL
万方数据
